ESC 365 - Should we use beta-blockers in all patients after st-segment elevation acute myocardial infarction?

ESC Premium Access

Should we use beta-blockers in all patients after st-segment elevation acute myocardial infarction?

Session: Beta blockers: required in all acute coronary syndromes?

Topic: Pharmacotherapy

Speaker: Doctor J. Ferreira (Coimbra, PT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Joao Ferreira

University Hospitals of Coimbra, Coimbra (Portugal)

2 presentations

0 follower

5 more presentations in this session

Beta-blockers and cardiovascular outcomes in patients hospitalized for acute coronary syndrome without heart failure

Effects of selective and nonselective beta-blockers on platelet aggregation in patients with acute coronary syndrome: the PLATE-BLOCK study

Speaker: Doctor F. Ilardi (Napoly, IT)

Guideline recommended therapies and clinical outcomes according to the risk for recurrent cardiovascular events after an acute coronary syndrome

Speaker: Doctor Y. Hammer (Petah Tikva, IL)

The effect of optimal medical therapy on hospital discharge on 3-year mortality after acute myocardial infarction in patients undergoing primary percutaneous intervention

Speaker: Assistant Professor Z. Mehmedbegovic (Belgrade, RS)

One year survival benefit of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in acute coronary syndrome undergoing PCI according to left ventricular ejection fraction.

Speaker: Doctor M. Cespon Fernandez (Brussels, BE)

Access the full session

Beta blockers: required in all acute coronary syndromes?

Speakers: Doctor J. Ferreira, Doctor F. Ilardi, Doctor Y. Hammer, Assistant Professor Z. Mehmedbegovic, Doctor M. Cespon Fernandez

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources